Pragmatic Adaptive Experiment — Real-World Adaptive Trial Design
Pragmatic Adaptive Trial Design · Also known as: pragmatic adaptive trial, real-world adaptive trial, PAT, adaptive pragmatic RCT
A pragmatic adaptive experiment is a hybrid clinical trial design that combines the real-world generalizability of pragmatic trials with the statistical flexibility of adaptive designs. It enrolls a broad, representative patient population under routine care conditions, while using pre-specified interim analyses to modify trial parameters — such as sample size, allocation ratios, or arm selection — as outcome data accumulate. The result is a design that is both externally valid and resource-efficient.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use a pragmatic adaptive experiment when the primary question is real-world comparative effectiveness rather than tightly controlled efficacy, AND when there is genuine uncertainty about optimal sample size, treatment effect heterogeneity across subgroups, or whether all arms will remain viable throughout the trial. It is especially well-suited to healthcare system-embedded research where electronic health records can serve as the data infrastructure. Do not use this design when the treatment under study requires strict protocol-mandated delivery that cannot be adapted to routine care (which would undermine pragmatism), or when regulatory requirements demand a fixed, fully pre-specified confirmatory design without adaptive modifications. It is also inappropriate when the statistical team lacks experience with adaptive methods, as poorly implemented adaptations can introduce bias or inflate type I error.
Strengths & limitations
- Maximizes external validity by testing interventions under routine care conditions with broadly eligible participants.
- Improves efficiency — early stopping for futility or superiority reduces time and cost compared to fixed designs.
- Allows sample size re-estimation and arm selection based on emerging data, making better use of limited resources.
- Findings are directly relevant to clinical decision-making and health policy, bridging the gap between efficacy and effectiveness.
- Leverages electronic health record infrastructure, reducing data collection burden on participants and sites.
- Requires sophisticated statistical expertise to pre-specify adaptive rules and conduct simulations before the trial begins.
- Operational complexity is high: independent Data Safety and Monitoring Boards, blinding procedures, and locked analysis plans are all essential.
- Real-world data quality from electronic health records is variable; missing data and inconsistent recording can threaten validity.
- Regulators may require extensive justification and simulation evidence before approving adaptive modifications, adding upfront time costs.
Frequently asked
How does a pragmatic adaptive trial differ from a standard adaptive trial?
A standard adaptive trial typically operates in a controlled, explanatory setting with strict eligibility criteria and protocol-mandated care delivery. A pragmatic adaptive trial adds real-world fidelity: broad eligibility, routine care settings, and clinically meaningful outcomes. Both use pre-specified interim rules, but the pragmatic variant prioritizes external validity and health system embedding alongside efficiency gains.
Does adding adaptive features compromise the pragmatic nature of the trial?
Not inherently. Adaptive modifications — such as arm dropping or sample size re-estimation — are procedural decisions made by the trial team, not changes to how care is delivered to patients. The pragmatic character lies in the care delivery context and eligibility breadth, which remain unchanged. Careful pre-specification ensures both dimensions are preserved.
What is the role of the PRECIS-2 tool in this design?
PRECIS-2 (PRagmatic–Explanatory Continuum Indicator Summary 2) is a validated instrument with nine domains — such as eligibility, recruitment setting, flexibility of intervention, and outcome relevance — that rates how pragmatic a trial is on a 1–5 scale. It is used during design to identify and resolve tensions between pragmatic goals and adaptive complexity, and during reporting to document the trial's pragmatism profile.
Can this design be used for regulatory (confirmatory) submissions?
Yes, but it requires close early engagement with the relevant regulatory agency. The FDA and EMA both accept adaptive designs in confirmatory submissions when adaptive rules are fully pre-specified, type I error is controlled, and the trial maintains blinding of interim results outside the DSMB. A purely pragmatic, non-regulatory effectiveness study faces fewer constraints.
What infrastructure is needed to run a pragmatic adaptive trial?
At minimum: a clinical data system (ideally an electronic health record) capable of near-real-time outcome extraction, a locked statistical analysis plan with simulation results, an independent Data Safety and Monitoring Board with adaptive design expertise, and a trial management team experienced in executing protocol amendments triggered by interim analyses.
Sources
- Pallmann, P., Bedding, A. W., Choodari-Oskooei, B., Dimairo, M., Flight, L., Hampson, L. V., ... & Sydes, M. R. (2018). Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Medicine, 16(1), 29. DOI: 10.1186/s12916-018-1017-7 ↗
- Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., ... & Chalkidou, K. (2009). A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Journal of Clinical Epidemiology, 62(5), 464–475. DOI: 10.1016/j.jclinepi.2008.12.011 ↗
How to cite this page
ScholarGate. (2026, June 3). Pragmatic Adaptive Trial Design. ScholarGate. https://scholargate.app/en/experimental-design/pragmatic-adaptive-experiment
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Adaptive Trial DesignClinical Research↔ compare
- Cluster Randomized TrialClinical Research↔ compare
- Randomized Controlled TrialExperimental design↔ compare